Credit Suisse’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-536,076
| Closed | -$18.5M | – | 3645 |
|
|
2020
Q3 | $18.5M | Buy |
536,076
+370,958
| +225% | +$12.8M | 0.01% | 777 |
|
|
2020
Q2 | $2.76M | Buy |
165,118
+115,849
| +235% | +$1.94M | ﹤0.01% | 1643 |
|
|
2020
Q1 | $711K | Sell |
49,269
-6,603
| -12% | -$95.3K | ﹤0.01% | 2338 |
|
|
2019
Q4 | $1.87M | Buy |
55,872
+22,454
| +67% | +$751K | ﹤0.01% | 2080 |
|
|
2019
Q3 | $699K | Buy |
33,418
+2,385
| +8% | +$49.9K | ﹤0.01% | 2604 |
|
|
2019
Q2 | $646K | Sell |
31,033
-5,368
| -15% | -$112K | ﹤0.01% | 2634 |
|
|
2019
Q1 | $814K | Buy |
36,401
+2,686
| +8% | +$60.1K | ﹤0.01% | 2507 |
|
|
2018
Q4 | $807K | Buy |
33,715
+6,740
| +25% | +$161K | ﹤0.01% | 2452 |
|
|
2018
Q3 | $737K | Sell |
26,975
-16,185
| -38% | -$442K | ﹤0.01% | 2616 |
|
|
2018
Q2 | $1.16M | Sell |
43,160
-17,689
| -29% | -$475K | ﹤0.01% | 2485 |
|
|
2018
Q1 | $1.94M | Buy |
60,849
+26,830
| +79% | +$854K | ﹤0.01% | 2088 |
|
|
2017
Q4 | $1.29M | Sell |
34,019
-6,690
| -16% | -$253K | ﹤0.01% | 2353 |
|
|
2017
Q3 | $1.01M | Buy |
40,709
+9,315
| +30% | +$231K | ﹤0.01% | 2637 |
|
|
2017
Q2 | $645K | Sell |
31,394
-11,051
| -26% | -$227K | ﹤0.01% | 2606 |
|
|
2017
Q1 | $924K | Buy |
42,445
+5,248
| +14% | +$114K | ﹤0.01% | 2572 |
|
|
2016
Q4 | $760K | Buy |
37,197
+15,231
| +69% | +$311K | ﹤0.01% | 2883 |
|
|
2016
Q3 | $329K | Buy |
21,966
+6,487
| +42% | +$97.2K | ﹤0.01% | 3288 |
|
|
2016
Q2 | $167K | Sell |
15,479
-3,296
| -18% | -$35.6K | ﹤0.01% | 3626 |
|
|
2016
Q1 | $255K | Buy |
+18,775
| New | +$255K | ﹤0.01% | 3289 |
|
|
2015
Q4 | – | Sell |
-65,924
| Closed | -$1.67M | – | 4117 |
|
|
2015
Q3 | $1.67M | Buy |
+65,924
| New | +$1.67M | ﹤0.01% | 2219 |
|